These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 1282664

  • 1. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N, Schols D, De Clercq E, Debyser Z, Pauwels R, Balzarini J, Nakashima H, Baba M, Hosoya M, Snoeck R.
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [Abstract] [Full Text] [Related]

  • 2. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M, Fikkert V, Pluymers W, Matthews B, Mardel K, Schols D, Raff J, Debyser Z, De Clercq E, Holan G, Pannecouque C.
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [Abstract] [Full Text] [Related]

  • 3. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW, Schols D, Pauwels R, De Clercq E, Meijer DK.
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [Abstract] [Full Text] [Related]

  • 4. Selective virus inhibitors.
    De Clercq E.
    Microbiologica; 1990 Apr; 13(2):165-78. PubMed ID: 1693749
    [Abstract] [Full Text] [Related]

  • 5. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
    Ichimura H, Levy JA.
    Virology; 1995 Aug 20; 211(2):554-60. PubMed ID: 7544050
    [Abstract] [Full Text] [Related]

  • 6. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
    Leydet A, Moullet C, Roque JP, Witvrouw M, Pannecouque C, Andrei G, Snoeck R, Neyts J, Schols D, De Clercq E.
    J Med Chem; 1998 Dec 03; 41(25):4927-32. PubMed ID: 9836609
    [Abstract] [Full Text] [Related]

  • 7. Polyanion inhibitors of human immunodeficiency virus and other viruses. Part 2. Polymerized anionic surfactants derived from amino acids and dipeptides.
    Leydet A, El Hachemi H, Boyer B, Lamaty G, Roque JP, Schols D, Snoeck R, Andrei G, Ikeda S, Neyts J, Reymen D, Este J, Witvrouw M, De Clercq E.
    J Med Chem; 1996 Apr 12; 39(8):1626-34. PubMed ID: 8648602
    [Abstract] [Full Text] [Related]

  • 8. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
    Jansen RW, Molema G, Pauwels R, Schols D, De Clercq E, Meijer DK.
    Mol Pharmacol; 1991 Jun 12; 39(6):818-23. PubMed ID: 2051994
    [Abstract] [Full Text] [Related]

  • 9. Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.
    Esimone CO, Grunwald T, Nworu CS, Kuate S, Proksch P, Uberla K.
    Chemotherapy; 2009 Jun 12; 55(2):119-26. PubMed ID: 19155620
    [Abstract] [Full Text] [Related]

  • 10. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
    Mohan P, Singh R, Baba M.
    Drug Des Discov; 1991 Nov 12; 8(1):69-82. PubMed ID: 1725723
    [Abstract] [Full Text] [Related]

  • 11. Polyanion inhibitors of human immunodeficiency virus and other viruses. 5. Telomerized anionic surfactants derived from amino acids.
    Leydet A, Barragan V, Boyer B, Montéro JL, Roque JP, Witvrouw M, Este J, Snoeck R, Andrei G, De Clercq E.
    J Med Chem; 1997 Jan 31; 40(3):342-9. PubMed ID: 9022800
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K, Pretzer E, Düzgünes N.
    Biochem Biophys Res Commun; 1995 Mar 08; 208(1):75-81. PubMed ID: 7887968
    [Abstract] [Full Text] [Related]

  • 13. [Antiviral strategies in the replication of human immunodeficiency virus].
    Wainberg MA, Bour S, Geleziunas R, Bentwich Z.
    Union Med Can; 1992 Mar 08; 121(5):307-9, 312-4. PubMed ID: 1279875
    [Abstract] [Full Text] [Related]

  • 14. Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors.
    Mohan P, Schols D, Baba M, De Clercq E.
    Antiviral Res; 1992 Jun 08; 18(2):139-50. PubMed ID: 1384428
    [Abstract] [Full Text] [Related]

  • 15. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
    Schols D, Wutzler P, Klöcking R, Helbig B, De Clercq E.
    J Acquir Immune Defic Syndr (1988); 1991 Jun 08; 4(7):677-85. PubMed ID: 1675677
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.